1.AHRQ. Methods guide for medical test reviews (draft). Rockville, MD: Agency for Healthcare Research and Quality; 2010.
2.Albon E, Tsourapas A, Frew E, et al. Structural neuroimaging in psychosis: A systematic review and economic evaluation. Health Technol Assess. 2008;12:iii–iv, ix-163.
3.Bossuyt PM, Irwig L, Craig J, Glasziou P. Diagnosis - Comparative accuracy: Assessing new tests against existing diagnostic pathways. BMJ. 2006;332:1089–1092.
4.Bossuyt PM, Lijmer JG, Mol BW, et al. Randomised comparisons of medical tests: Sometimes invalid, not always efficient. Lancet. 2000;356:1844–1847.
5.Bossuyt PM, Reitsma JB, Bruns DE, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD initiative. BMJ. 2003;326:41–44.
6.EUnetHTA. HTA core model for diagnostic technologies v 1.0r. Copenhagen: European Network for Health Technology Assessment; 2008.
7.Fryback DG, Thornbury JR. The efficacy of diagnostic imaging. Med Decis Making. 1991;11:88–94.
8.Glasziou PP, Aronson JK. An introduction to monitoring therapeutic interventions in clinical practice. In: Glasziou PP, Irwig L, Aronson JK, eds. Evidence-based medical monitoring. Malden, MA: BMJ Books; 2008.
9.Grootendorst DC, Jager KJ, Zoccali C, Dekker FW. Screening: Why, when, and how. Kidney Int. 2009;76:694–699.
10.Guyatt GH, Tugwell PX, Feeny DH, et al. The role of before after studies of therapeutic impact in the evaluation of diagnostic technologies. J Chronic Dis. 1986;39:295–304.
11.Higgins JPT, Altman DG. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions. Version 5.0.1 (updated September 2008). CochraneCollaboration; 2008.
12.Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials. 1996;17:1–12.
13.Knottnerus JA, van Weel C, Muris JWM. Evidence base of clinical diagnosis—Evaluation of diagnostic procedures. BMJ. 2002;324:477–480.
14.Lijmer JG, Leeflang M, Bossuyt PM. Proposals for a phased evaluation of medical tests. Med Decis Making. 2009;29:E13–E21.
15.Lord SJ, Irwig L, Simes RJ. When is measuring sensitivity and specificity sufficient to evaluate a diagnostic test, and when do we need randomized trials? Ann Intern Med. 2006;144:850–855.
16.Meads CA, Davenport CF. Quality assessment of diagnostic before-after studies: Development of methodology in the context of a systematic review. BMC Med Res Methodol. 2009;9:3.
17.Moher D, Schulz KF, Altman DG. The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med. 2001;134:657–662.
18.MSAC. Guidelines for the assessment of diagnostic technologies. Canberra: Medical Services Advisory Committee (MSAC), Commonwealth of Australia; 2005.
19.MSAC. Positron emission tomography for head and neck cancer. Canberra: Medical Services Advisory Committee (MSAC), Commonwealth of Australia; 2008.
20.NICE. Diagnostics assessment programme; Interim methods statement (March 2010). London: National Institute for Health and Clinical Excellence; 2010.
21.Pawson RF, Greenhalgh TF, Harvey GF, Walshe K. Realist review - a new method of systematic review designed for complex policy interventions. J Health Serv Res Policy. 2005;10:21–34.
22.Pepe MS. Introduction. In: Pepe MS, ed. The statistical evaluation of medical tests for classification and prediction. Oxford: Oxford University Press; 2003.
23.Piper MA, Aronson N, Ziegler KM, et al. Special report: Fecal DNA analysis for colon cancer screening. Assessment program 21(6). Blue Cross Blue Shield Association; 2006.
24.Scott AM, Gunawardana DH, Bartholomeusz D, et al. PET changes management and improves prognostic stratification in patients with head and neck cancer: Results of a multicenter prospective study. J Nucl Med. 2008;49:1593–1600.
25.Staub LP, Lord SJ, Simes RJ, et al. . Using patient management as a proxy for patient outcomes in test evaluation. Methods for Evaluating Medical Tests and Biomarkers 2nd Symposium; 1–2 July 2010; Birmingham: 41.
26.Whiting P, Rutjes AW, Reitsma JB, et al. The development of QUADAS: A tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003;3:25.